Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SETD7 | Q8WTS6 | 2/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.37 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9282186 | 0.99 | SETD7 (0.43) | SETD7USP2SMN1; SMN2NR1H2HPGD | |
| SCHEMBL4336794 | 0.85 | SETD7 (0.52) | SETD7USP2SMN1; SMN2NR1H2HPGD | |
| SCHEMBL27622979 | 0.83 | PARP1 (0.39) | SETD7USP2SMN1; SMN2NR1H2HPGD | |
| SCHEMBL132585 | 0.82 | USP2 (0.56) | USP2SMN1; SMN2NR1H2HPGDEPHX2 | |
| Bromide SCHEMBL29757584 | 0.82 | USP2 (0.56) | USP2SMN1; SMN2NR1H2HPGDEPHX2 | |
| SCHEMBL2220355 | 0.82 | USP2 (0.56) | USP2SMN1; SMN2NR1H2HPGDEPHX2 | |
| Bromide SCHEMBL583319 | 0.81 | NR1H2 (0.39) | SETD7USP2SMN1; SMN2NR1H2HPGD | |
| SCHEMBL17297711 | 0.81 | USP2 (0.55) | USP2SMN1; SMN2NR1H2HPGDEPHX2 | |
| SCHEMBL12005408 | 0.81 | USP2 (0.58) | USP2SMN1; SMN2NR1H2HPGDEPHX2 | |
| SCHEMBL8286 | 0.81 | USP2 (0.58) | USP2SMN1; SMN2NR1H2HPGDEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0755269-B1 | CONTRAST AGENTS | AMERSHAM HEALTH SALUTAR INC (US) | 2005-12-07 | — | — | EP | disclosed |
| EP-0785804-B1 | LIPOSOMAL AGENTS | AMERSHAM HEALTH SALUTAR INC (US) | 2004-06-23 | — | — | EP | disclosed |
| US-6045821-A | CHELATE COMPOUND IMMOBILIZED ON MEMBRANE WHEREBY THE CHELATING AGENT COMPRISES A MACROCYCLIC CHELANT MOIETY WITH A LIPOPHILIC MEMBRANE ASSOCIATING MOIETY ATTACHED TO RING ATOM; ORGANOMETALLIC COMPOUND MEDICAL DIAGNOSTIC AGENTS | NYCOMED SALUTAR, INC. (US) | 2000-04-04 | — | — | US | disclosed |
| US-6010681-A | CHELATE COMPOUND | NYCOMED SALUTAR, INC. (US) | 2000-01-04 | — | — | US | disclosed |
| EP-0785804-A1 | LIPOSOMAL AGENTS | NYCOMED SALUTAR, INC. (US) | 1997-07-30 | — | — | EP | disclosed |
| EP-0755269-A1 | CONTRAST AGENTS | NYCOMED SALUTAR, INC. (US) | 1997-01-29 | — | — | EP | disclosed |
| WO-1996011023-A1 | LIPOSOMAL AGENTS | NYCOMED SALUTAR INC. (US) | 1996-04-18 | — | — | WO | disclosed |
| WO-1995028967-A1 | CONTRAST AGENTS | NYCOMED SALUTAR INC (US) | 1995-11-02 | — | — | WO | disclosed |